Onward Therapeutics has exercised its exclusive option to enter a worldwide license agreement with Institut du Cancer de Montpellier to advance its onco-metabolism program. This license agreement follows an earlier collaboration aimed at discovering promising compounds for cancer treatment.
Company Information
Company
Onward Therapeutics SA
Location
4 Route de la Corniche
Vaud, Switzerland
About
Onward Therapeutics SA is a clinical stage oncology company focused on developing innovative therapies for cancer treatment. With a commitment to advancing onco-metabolism programs, they aim to identify and develop promising compounds for effective cancer care. The company's research efforts are geared towards translating scientific discoveries into breakthrough therapeutic solutions.
Predictive Intelligence
Strategic
ML-powered predictions for Onward Therapeutics SA's next move
VaudBiotechnologyHealth CareMedicalTherapeuticsresearch